Biofrontera Inc. Fair Value of Assets Acquired
Biofrontera Inc. (BFRI) reported Fair Value of Assets Acquired of $2.13 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2026-03-19
- Biofrontera Inc. fair value of assets acquired for the quarter ending 2021-12-31 was -$5.00K.
- Biofrontera Inc. fair value of assets acquired for fiscal 2025 was $2.13M.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|
| 2025-12-31 | $2.13M 10-K · filed 2026-03-19 | ||
| 2021-12-31 | -$5.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $8.00K 8-K · filed 2023-10-03 | |
| 2021-09-30 | $13.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |